Abstract
Major depressive disorder (MDD) is a highly prevalent and disabling condition for which the currently available treatments are not fully effective. Existing unmet needs include rapid onset of action and optimal management of concurrent agitation. Dexmedetomidine (DEX) is a selective and potent α2-adrenergic receptor (α2-AR) agonist, with unique pharmacokinetic and pharmacodynamic properties. In this review, we discuss pre-clinical and clinical studies which focused on DEX in the context of its putative antidepressant effects for the management of MDD. Preliminary data support DEX as an antidepressant with fast onset of action, which would be especially helpful for patients experiencing treatment resistant depression, and agitation. We further explore the mechanistic and clinical implications of considering DEX as a putative antidepressant agent, and the next steps to explore the efficacy of low dose DEX infusion among patients with treatment resistant depression.
Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None.
Conflict of interest statement: The authors declare no conflicting interests regarding this article.
References
Alam, A., Suen, K.C., Hana, Z., Sanders, R.D., Maze, M., and Ma, D. (2017). Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon. Neurotoxicol. Teratol. 60: 102–116, https://doi.org/10.1016/j.ntt.2017.01.001.Search in Google Scholar PubMed
Alexander, S.P., Davenport, A.P., Kelly, E., Marrion, N., Peters, J.A., Benson, H.E., Faccenda, E., Pawson, A.J., Sharman, J.L., Southan, C., et al. (2015). The concise guide to Pharmacology 2015/16: g protein-coupled receptors. Br. J. Pharmacol. 172: 5744–5869, https://doi.org/10.1111/bph.13348.Search in Google Scholar PubMed PubMed Central
Baarslag, M.A., Allegaert, K., Knibbe, C.A.J., van Dijk, M., and Tibboel, D. (2017). Pharmacological sedation management in the paediatric intensive care unit. J. Pharm. Pharmacol. 69: 498–513, https://doi.org/10.1111/jphp.12630.Search in Google Scholar PubMed
Biccard, B.M., Goga, S., and Buers, J.D. (2008). Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials. Anaesthesia 63: 4–14, https://doi.org/10.1111/j.1365-2044.2007.05306.x.Search in Google Scholar PubMed
Bougarel, L., Guitton, J., Zimmer, L., Vaugeois, J.M., and El Yacoubi, M. (2011). Behaviour of a genetic mouse model of depression in the learned helplessness paradigm. Psychopharmacology (Berl) 215: 595–605, https://doi.org/10.1038/npp.2008.23.Search in Google Scholar PubMed
Chandanwale, A., Langade, D., Sonawane, D., and Gava, P. (2017). A randomized, clinical trial to evaluate efficacy and tolerability of trypsin:chymotrypsin as compared to serratiopeptidase and trypsin:bromelain:rutoside in wound management. Adv. Ther. 34: 180–198, http://doi.org/10.1007/s12325-017-0496-9.10.1007/s12325-016-0444-0Search in Google Scholar PubMed
Constantin, J.M., Momon, A., Mantz, J., Payen, J.F., De Jonghe, B., Perbet, S., Cayot, S., Chanques, G., and Perreira, B. (2016). Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials. Anaesth. Crit. Care Pain Med. 35: 7–15, https://doi.org/10.1016/j.accpm.2015.06.012.Search in Google Scholar PubMed
Dahmani, S., Rouelle, D., Gressens, P., and Mantz, J. (2005). Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anaesthesia 103 969–977, https://doi.org/10.1097/00000542-200511000-00011.Search in Google Scholar PubMed
Dunlop, B.W. and Nemeroff, C.B. (2007). The role of dopamine in the pathophysiology of depression. Arch. Gen. Psychiatr. 64: 327–337, https://doi.org/10.1001/archpsyc.64.3.327.Search in Google Scholar PubMed
Dunne, R.A. and McLoughlin, D.M. (2012). Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J. Biol. Psychiatr. 13: 248–258, https://doi.org/10.3109/15622975.2011.615863.Search in Google Scholar PubMed
Ebert, T.J., Hall, J.E., Barney, J.A., Uhrich, T.D., and Colinco, M.D. (2000). The effects of increasing plasma concentrations of dexmedetomidine in humans. Anaesthesia 93: 382–394, https://doi.org/10.1097/00000542-200008000-00016.Search in Google Scholar
Esler, M., Jennings, G., Korner, P., Willett, I., Dudley, F., Hasking, G., Anderson, W., and Lambert, G. (1988). Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11: 3–20, https://doi.org/10.1161/01.HYP.11.1.3.Search in Google Scholar
Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biol. Psychiatr. 53: 649–659, https://doi.org/10.1016/S0006-3223(03)00231-2.Search in Google Scholar
Fekadu, A., Donocik, J.G., and Cleare, A.J. (2018). Standardisation framework for the Maudsley staging method for treatment resistance in depression. BMC Psychiatr. 18: 100, https://doi.org/10.1186/s12888-018-1679-x.Search in Google Scholar
Fried, E.I. (2015). Problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward. Front. Psycho. 6: 309, https://doi.org/10.3389/fpsyg.2015.00309.Search in Google Scholar
Gao, X., Zhuang, F.Z., Qin, S.J., Zhou, L., Wang, Y., Shen, Q.F., Li, M., Villarreal, M., Benefield, L., Gu, S.L., et al. (2016). Dexmedetomidine protects against learning and memory impairments caused by electroconvulsive shock in depressed rats: involvement of the NMDA receptor subunit 2B (NR2B)-ERK signaling pathway. Psychiatr. Res. 243: 446–452, https://doi.org/10.1016/j.psychres.2016.07.020.Search in Google Scholar
García-Sevilla, J.A., Ventayol, P., Pérez, V., Rubovszky, G., Puigdemont, D., Ferrer-Alcón, M., Andreoli, A., Guimón, J., and Alvarez, E. (2004). Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology 29: 580–588, https://doi.org/10.1038/sj.npp.1300356.Search in Google Scholar
Gass, N., Becker, R., Sack, M., Schwarz, A.J., Reinwald, J., Cosa-Linan, A., Zheng, L., von Hohenberg, C.C., Inta, D., Meyer-Lindenberg, A., et al. (2018). Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior. Psychopharmacology (Berl) 235: 1055–1068, https://doi.org/10.1016/j.biopsych.2005.09.009.Search in Google Scholar
GBD 2015 DALYs and HALE Collaborators, Kassebaum, N.J., Arora, M., Barber, R.M., Bhutta, Z.A., Brown, J., Carter, A. (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet 388: 1603–1658, https://doi.org/10.1016/S0140-6736(16)31460-X.Search in Google Scholar
Gold, P.W., Goodwin, F.K., and Chrousos, G.P. (1988). Clinical and biochemical manifestations of depression: relation to the neurobiology of stress (2). N. Engl. J. Med. 319: 413–420, https://doi.org/10.1155/2015/581976.Search in Google Scholar PubMed PubMed Central
Gu, J., Sun, P., Zhao, H., Watts, H.R., Sanders, R.D., Terrando, N., Xia, P., Maze, M., and Ma, D. (2011). Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit. Care 15: R153, https://doi.org/10.1186/cc10283.Search in Google Scholar PubMed PubMed Central
Holmes, A., Li, Q., Koenig, E.A., Gold, E., Stephenson, D., Yang, R.J., Dreiling, J., Sullivan, T., and Crawley, J.N. (2005). Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior. Psychopharmacology (Berl) 178: 276–285, https://doi.org/10.1007/s00213-004-1997-1.Search in Google Scholar PubMed
Husain, M.M., Rush, A.J., Fink, M., Knapp, R., Petrides, G., Rummans, T., Biggs, M.M., O’Connor, K., Rasmussen, K., Litle, M., et al. (2004). Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report. J. Clin. Psychiatr. 65: 485–491.10.4088/JCP.v65n0406Search in Google Scholar PubMed
Ji, M.H., Jia, M., Zhang, M.Q., Liu, W.X., Xie, Z.C., Wang, Z.Y., and Yang, J.J. (2014). Dexmedetomidine alleviates anxiety-like behaviors and cognitive impairments in a rat model of post-traumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatr. 54: 284–288, https://doi.org/10.1016/j.pnpbp.2014.06.013.Search in Google Scholar PubMed
Ji, E.S., Lee, J.M., Kim, T.W., Kim, Y.M., Kim, Y.S., and Kim, K. (2017). Treadmill exercise ameliorates depressive symptoms through increasing serotonin expression in postpartum depression rats. J. Exerc. Rehabil. 13: 130–135, https://doi.org/10.12965/Fjer.1734968.484.Search in Google Scholar
Jun, J.H., Kim, K.N., Kim, J.Y., and Song, S.M. (2017). The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can. J. Anaesth. 64: 947–961, https://doi.org/10.1007/s12630-017-0917-x.Search in Google Scholar PubMed
Kim, S.E., Ko, I.G., Kim, C.J., Chung, J.Y., Yi, J.W., Choi, J.H., Jang, M.S., and Han, J.H. (2016). Dexmedetomidine promotes the recovery of the field excitatory postsynaptic potentials (fEPSPs) in rat hippocampal slices exposed to oxygen-glucose deprivation. Neurosci. Lett. 631: 91–96, https://doi.org/10.1016/j.neulet.2016.08.033.Search in Google Scholar PubMed
Kraus, C., Kadriu, B., Lanzenberger, R., ZarateJrC.A., and Kasper, S. (2019). Prognosis and improved outcomes in major depression: a review. Transl. Psychiatr. 9: 127, https://doi.org/10.1038/s41380-018-0093-6.Search in Google Scholar PubMed PubMed Central
Lake, C.R., Chernow, B., Feuerstein, G., Goldstein, D.S., and Ziegler, M.G. (1984). The sympathetic nervous system in man: its evaluation and measurement of plasma norepinephrine. In: Ziegler, M.G. and Lake, C.R. (Eds.), Norepinephrine. Williams & Wilkins, Baltimore, MD, pp. 70–80.Search in Google Scholar
Landau, A.M., Phan, J.A., Iversen, P., Lillethorup, T.P., Simonsen, M., Wegener, G., Jakobsen, S., and Doudet, D.J. (2015). Decreased in vivo α2 adrenoceptor binding in the flinders sensitive line rat model of depression. Neuropharmacology 91: 97–102, https://doi.org/10.1016/j.neuropharm.2014.12.025.Search in Google Scholar PubMed
Lim, G.Y., Tam, W.W., Lu, Y., Ho, C.S., Zhang, M.W., and Ho, R.C. (2018). Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci. Rep. 8: 2861, https://doi.org/10.1136/bmj.i1617.Search in Google Scholar PubMed
MacMillan, L.B., Hein, L., Smith, M.S., Piascik, M.T., and Limbird, L.E. (1996). Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 273: 801–803, https://doi.org/10.1126/science.273.5276.801.Search in Google Scholar PubMed
Mason, K.P., Zurakowski, D., Zgleszewski, S.E., Robson, C.D., Carrier, M., Hickey, P.R., and Dinardo, J.A. (2008). High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr. Anaesth. 18: 403–411, https://doi.org/10.1111/j.1460-9592.2008.02468.x.Search in Google Scholar PubMed
Mathers, C.D. and Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3: e442, https://doi.org/10.1371/journal.pmed.0030442.Search in Google Scholar PubMed PubMed Central
McCutcheon, C.A., Orme, R.M., Scott, D.A., Davies, M.J., and McGlade, D.P. (2006). A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth. Analg. 102: 668–675, https://doi.org/10.1213/01.ane.0000197777.62397.d5.10.1213/01.ane.0000197777.62397.d5Search in Google Scholar PubMed
Molero, P., Ramos-Quiroga, J.A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., and Meana, J.J. (2018). Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs 32: 411–420.10.1007/s40263-018-0519-3Search in Google Scholar PubMed
Moon, E.J., Ko, I.G., Kim, S.E., Jin, J.J., Hwang, L., Kim, C.J., An, H., Lee, B.J., and Yi, J.W. (2018). Dexmedetomidine ameliorates sleep deprivation-induced depressive behaviors in mice. Int. Neurourol. J. 22: S139–146, https://doi.org/10.5213/Finj.1836228.114.Search in Google Scholar
Moylan, S., Maes, M., Wray, N.R., and Berk, M. (2013). The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatr. 18: 595–606, https://doi.org/10.1038/mp.2012.33.Search in Google Scholar PubMed
Nutt, D.J. (2008). Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiatr. 69: 4–7.Search in Google Scholar
Pancaro, C., Segal, B.S., Sikes, R.W., Almeer, Z., Schumann, R., Azocar, R.J., and Marchand, J.E. (2016). Dexmedetomidine and ketamine show distinct patterns of cell degeneration and apoptosis in the developing rat neonatal brain. J. Matern. Fetal. Neonatal Med. 29: 3827–3833, https://doi.org/10.3109/14767058.2016.1148132.Search in Google Scholar PubMed
Reade, M.C., O’Sullivan, K., Bates, S., Goldsmith, D., Ainslie, W.R.S.T.J., and Bellomo, R. (2009). Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit. Care 13: R75, https://doi.org/10.1186/cc7890.Search in Google Scholar PubMed PubMed Central
Rivero, G., Martin-Guerrero, I., de Prado, E., Gabilondo, A.M., Callado, L.F., García-Sevilla, J.A., García-Orad, A., and Meana, J.J. (2016). Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence. World. J. Biol. Psychiatry 17: 308–315, https://doi.org/10.3109/15622975.2016.1142608.Search in Google Scholar PubMed
Ryan, K.M. and McLoughlin, D.M. (2018). From molecules to mind: mechanisms of action of electroconvulsive therapy. Acta Psychiatr. Scand. 138: 177–179, https://doi.org/10.1111/acps.12951.Search in Google Scholar
Schramm, N.L., McDonald, M.P., and Limbird, L.E., (2001). The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J. Neurosci. 21: 4875–4882. https://doi.org/10.1523/JNEUROSCI.21-13-04875.2001.Search in Google Scholar
Scott-Warren, V.L. and Sebastian, J. (2015). Dexmedetomidine: its use in intensive care medicine and anaesthesia. BJA Educ. 16: 242–246, https://doi.org/10.1093/bjaed/mkv047.Search in Google Scholar
Shams, T. and El-Masry, R. (2014). Ketofol-dexmedetomidine combination in ECT: a punch for depression and agitation. Indian J. Anaesth. 58: 275–280, https://doi.org/10.4103/F0019-5049.135037.Search in Google Scholar
Siddappa, R., Riggins, J., Kariyanna, S., Calkins, P., and Rotta, A.T. (2011). High-dose dexmedetomidine sedation for pediatric MRI. Paediatr. Anaesth. 21: 153–158, https://doi.org/10.1111/j.1460-9592.2010.03502.x.Search in Google Scholar
Stahl, S.M., Zhang, L., Damatarca, C., and Grady, M. (2003). Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J. Clin. Psychiatr. 64: 6–17.Search in Google Scholar
Trendelenburg, A.U., Limberger, N., and Starke, K. (1993). Presynaptic α2-autoreceptors in brain cortex: α2d in the rat and α2a in the rabbit. Naunyn-Schmiedeberg’s Arch. Pharmacol. 348: 35–45, https://doi.org/10.1007/BF00168534.Search in Google Scholar
Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., Norquist, G., Howland, R.H., Lebowitz, B., McGrath, P.J., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatr. 163: 28–40, https://doi.org/10.1176/appi.ajp.163.1.28.Search in Google Scholar
Valdizán, E.M., Díez-Alarcia, R., González-Maeso, J., Pilar-Cuéllar, F., García-Sevilla, J.A., Meana, J.J., and Pazos, A. (2010). α2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biol. Psychiatr. 68: 869–872, https://doi.org/10.1016/j.biopsych.2010.07.023.Search in Google Scholar
Veith, R.C., Barnes, R.F., Villacres, E.C., Murburg, M.M., Raskind, M.A., Borson, S., Backus, F., and Halter, J.B. (1988). Plasma catecholamines and norepinephrine kinetics in depression and panic disorder. In: Belmaker, R. (Ed.). Catecholamines: clinical aspects. Alan R Liss Inc, New York, NY, pp. 197–202.Search in Google Scholar
Venn, R.M., Bryant, A., Hall, G.M., and Grounds, R.M. (2001). Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br. J. Anaesth. 86: 650–656, https://doi.org/10.1093/bja/86.5.650.Search in Google Scholar
Vos, T., Barber, R.M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 386: 743–800, https://doi.org/10.1016/S0140-6736(15)60692-4.Search in Google Scholar
Weerink, M.A.S., Struys, M.M.R.F, Hannivoort, L.N., Barends, C.R., Absalom, A.R., and Colin, P. (2017). Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin. Pharmacokinet. 56: 893–913, https://doi.org/10.1007/s13318-016-0333-6.Search in Google Scholar
Weiss, J.M. and Simson, P.E. (1988). Neurochemical and electrophysiological events underlying stress-induced depression in an animal model. Adv. Exp. Med. Biol. 245: 425–440, https://doi.org/10.1007/978-1-4899-2064-5_33.10.1007/978-1-4899-2064-5_33Search in Google Scholar
Wijeysundera, D.N., Naik, J.S., and Beattie, W.S. (2003). Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am. J. Med. 114: 742–752, https://doi.org/10.1016/S0002-9343(03)00165-7.Search in Google Scholar
Yu, H.Y., Wang, S.Y., Quan, C.X., Fang, C., Luo, S.C., Li, D.Y., Zhen, S.S., Ma, J.H., and Duan, K.M. (2019). Dexmedetomidine alleviates postpartum depressive symptoms following cesarean section in chinese women: a randomized placebo‐controlled study. Pharmacothera. 39: 994–1004, https://doi.org/10.1002/phar.2320.Search in Google Scholar PubMed
Yuen, V.M., Hui, T.W., Irwin, M.G., and Yuen, M.K. (2008). A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth. Analg. 106: 1715–1721, https://doi.org/10.1213/ane.0b013e31816c8929.Search in Google Scholar PubMed
Zheng, W., Cai, D.B., Sim, K., Ungvari, G.S., Peng, X.J., Ning, Y.P., Wang, G., and Xiang, Y.T. (2019). Brexanolone for postpartum depression: a meta-analysis of randomized controlled studies. Psychiatr Res. 279: 83–89, https://doi.org/10.1016/j.psychres.2019.07.006.Search in Google Scholar PubMed
Zhou, X., Ravindran, A.V., Qin, B., Del Giovane, C., Li, Q., Bauer, M., Liu, Y., Fang, Y., da Silva, T., Zhang, Y., et al. (2015). Comparative efficacy, acceptability, and tolerability of augmentation agents in treatmentresistant depression: systematic review and network meta-analysis. J. Clin. Psychiatr. 76: E487–498, https://doi.org/10.1093/ijnp/pyv060.Search in Google Scholar PubMed PubMed Central
© 2020 Walter de Gruyter GmbH, Berlin/Boston
